Skip to content

Released Aug 8, 2016, after the close

10-Q filed Aug 8, 2016, 39 days after period end · 0001104659-16-137990

Q2 2016 · 10-Q
Revenue$54.35M+95.9% vs Q2 2015−17.7% vs Q1 2016
Net Income-$21.70Mno prior Q2 2015 on fileN/M vs Q1 2016
EPS Diluted-$0.15N/M vs Q2 2015N/M vs Q1 2016
Operating Income-$15,315,000N/M
Operating Cash Flowderived-$6,263,000N/M
Free Cash Flowderived-$6,878,000N/M
Margins · derived
Operating margin-28.2%+123.2 pt vs Q2 2015
Net margin-39.9%

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ2 2016Q2 2015Q2 2014Q2 2013
Revenue$54.35M$27.74M$6.84M$9.66M
Net Income-$21.70M———
EPS Diluted-$0.15-$0.34-$0.44-$0.57

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ironwood Pharmaceuticals Inc · CIK 1446847 · Engraved from SEC EDGAR